Pembrolizumab in Small Cell Carcinoma of Ovary - Hypercalcemic Type Patient (Pemb-HT)
Latest Information Update: 18 Mar 2024
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Carcinoma; Ovarian cancer
- Focus Therapeutic Use
- Acronyms Pemb-HT
Most Recent Events
- 12 Mar 2024 Planned End Date changed from 6 Dec 2023 to 2 Nov 2024.
- 12 Mar 2024 Planned primary completion date changed from 6 Dec 2023 to 2 Nov 2024.
- 08 Jan 2023 Status changed from recruiting to active, no longer recruiting.